The U.S. Food and Drug Administration has withdrawn a long-pending proposed rule that would have prohibited minors from using tanning beds. The regulation, initially introduced over ten years ago, aimed to restrict access to indoor tanning devices for individuals under 18 and required adult consent through a risk acknowledgment form. Its removal marks a reversal in federal efforts to curb youth exposure to ultraviolet radiation linked to skin cancer. Health advocates have expressed concern, warning that the decision undermines public health protections and increases risks for young people.
The move follows ongoing debate about the safety of tanning bed use, particularly among adolescents. Critics argue that the FDA's retreat sends a conflicting message about the dangers of UV exposure. While the agency cited regulatory review as the reason for the withdrawal, stakeholders emphasize that tanning beds are classified as carcinogenic by major health organizations. The absence of the rule leaves current state-level regulations as the primary safeguard, though enforcement varies widely across jurisdictions.